Trial intelligence / Profile preview

Salivary viral load in COVID-19 after chlorhexidine mouthwash

RBR-3q6wqdfCompleted

Sponsor
Faculdade de Odontologia da Universidade Federal da Bahia
Start
Dec 2020
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Chlorhexidine mouthwash with Placebo mouthwash (2 arms). Primary endpoint: Salivary SARS-CoV-2 viral load. Started Dec 2020; status: completed.

02

Drugs

chlorhexidine
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on RBR-3q6wqdf.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-3q6wqdf.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call